LeMaitre Vascular, Inc.

LMAT ·Healthcare, Medical Devices, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Assets
Cash & Equivalents $28.2M $25.6M $24.3M $19.1M $13.9M $26.8M $11.8M $26.3M
Accounts Receivable $33.6M $30.1M $25.1M $22.0M $19.6M $19.6M $16.6M $15.7M
Inventory — — — — — — — —
Total Current Assets $468.2M $402.2M $194.6M $161.7M $139.9M $94.3M $92.1M $94.0M
Property, Plant & Equipment $27.0M $24.8M $21.8M $17.9M $17.1M $15.0M $14.9M $14.1M
Goodwill $65.9M $65.9M $65.9M $65.9M $65.9M $65.9M $40.0M $29.9M
Intangible Assets (Excl. Goodwill) $33.1M $35.8M $41.7M $46.5M $52.7M $58.9M $24.9M $13.7M
Total Assets $615.7M $551.8M $346.8M $310.5M $292.8M $252.8M $188.3M $153.1M
Liabilities
Accounts Payable $3.6M $1.8M $3.7M $2.9M $2.3M $2.4M $2.6M $1.7M
Total Current Liabilities $36.3M $30.6M $29.9M $25.3M $21.8M $25.1M $20.9M $19.8M
Long-Term Debt — — — — — — — —
Total Liabilities $222.2M $214.5M $48.9M $42.3M $38.7M $80.2M $40.2M $22.9M
Stockholders' Equity
Retained Earnings $184.7M $145.1M $115.4M $97.8M $88.1M $70.6M $57.0M $45.8M
Total Stockholders' Equity $393.5M $337.3M $297.9M $268.2M $254.2M $172.6M $148.1M $130.2M
← Newer Page 1 of 2 Older →